The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1101/256669
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Antimalarial pantothenamide metabolites target acetyl-CoA synthesis inPlasmodium falciparum

Abstract: Malaria eradication is critically dependent on novel drugs that target resistant Plasmodium parasites and block transmission of the disease. Here we report the discovery of potent pantothenamide bioisosteres that are active against blood-stage P. falciparum and also block onward mosquito transmission. These compounds are resistant to degradation by serum pantetheinases, show favorable pharmacokinetic properties and clear parasites in a humanized rodent infection model. Metabolomics revealed that CoA biosynthet… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 40 publications
(16 reference statements)
0
2
0
Order By: Relevance
“…It provides activated acyl groups for various metabolic pathways, such as the tricarboxylic acid cycle, fatty acid synthesis, and heme synthesis, as well as for gene regulation and post-translational modification of proteins (59). Pantothenate kinase (PanK), which catalyzes the first step in CoA synthesis, has been extensively characterized in P. falciparum (60), allowing pantothenamides (pantothenate mimetic compounds) to be catabolized into CoA antimetabolites (61) with deleterious effects for the parasite (62). Interestingly, of the five enzymes required for CoA synthesis, phosphopantetheine-cysteine ligase and phosphopantothenoylcysteine decarboxylase, which catalyze the second and third step, respectively, are dispensable in both the rodent malaria parasites Plasmodium yoelii and P. berghei (19,63).…”
Section: Vitamin Bmentioning
confidence: 99%
“…It provides activated acyl groups for various metabolic pathways, such as the tricarboxylic acid cycle, fatty acid synthesis, and heme synthesis, as well as for gene regulation and post-translational modification of proteins (59). Pantothenate kinase (PanK), which catalyzes the first step in CoA synthesis, has been extensively characterized in P. falciparum (60), allowing pantothenamides (pantothenate mimetic compounds) to be catabolized into CoA antimetabolites (61) with deleterious effects for the parasite (62). Interestingly, of the five enzymes required for CoA synthesis, phosphopantetheine-cysteine ligase and phosphopantothenoylcysteine decarboxylase, which catalyze the second and third step, respectively, are dispensable in both the rodent malaria parasites Plasmodium yoelii and P. berghei (19,63).…”
Section: Vitamin Bmentioning
confidence: 99%
“…Considering the extensive application of d -pantolactone in medicinal chemistry and in the cosmetics industry, we selected the ring-opening of d -pantolactone with piperonylamine (Figure ) as a model reaction to explore lactone aminolysis. Various additives with potential acyl-transfer ability were tested, including aprotic nucleophiles (Figure a), protic nucleophiles (Figure b), and miscellaneous promoters, classified based on their potential mechanism of action (Figure c).…”
Section: Resultsmentioning
confidence: 99%